SIPOC — Clinical Trial Site Activation
Bounds phase III site start-up at seven steps from site qualification to first patient screened, with three of its six inputs carrying a stated requirement and the 137-day activation cycle measured against a 90-day target.
Make it your own.
title "Clinical trial site activation — phase III oncology"
scope "Site selected" -> "First patient screened"
owner "Study start-up lead, EU region"
metric "Site activation cycle" target: 90 actual: 137 unit: days
metric "Sites activated per month" target: 6 actual: 3.5 better: higher
metric "Protocol deviations in month one" target: 0 actual: 2
suppliers: Sponsor study team, Central ethics committee, Contract research organisation, Central laboratory
inputs: Approved protocol, Investigator brochure, Signed clinical trial agreement, Ethics approval letter, Delegation of authority log, Investigational product shipment
process steps: Qualify site -> Negotiate budget and contract -> Submit to ethics -> Train site staff
-> Release investigational product -> Activate site -> Screen first patient
outputs: Activation memo, Trained and delegated site staff, Released drug supply, Site initiation visit report
customers: Principal investigator, Study participants, Sponsor operations, Regulatory authorities
requirement input "Signed clinical trial agreement": "Fully executed by sponsor and institution before activation" (CTQ)
requirement input "Ethics approval letter": "Covers the current protocol version and every site document" (CTQ)
requirement input "Investigational product shipment": "Free of temperature excursions, accountability log received"
requirement output "Trained and delegated site staff": "Every delegated task signed before first patient contact" (CTQ)
requirement output "Site initiation visit report": "Filed in the trial master file inside 10 working days"